Prevalence and risk factors for vitamin D insufficiency among children with epilepsy.
This cross-sectional study was designed to determine the prevalence of, and risk factors for, vitamin D insufficiency among children treated for epilepsy in a general pediatric neurology clinic. Included were 78 children with epilepsy, aged 3-17 years, treated by the authors between September 2008 and March 2009. Vitamin D levels and relevant risk factors were evaluated using multiple logistic regression. Of the 78 children, 41% were male and 81% were of European origin; the mean age was 11.64 + or - 4.37 years. 25-hydroxyvitamin D levels of <20 ng/mL were observed in 25% of the children and levels considered to be normal (>32 ng/mL) were observed in only 25%. Girls and children with elevated body mass index were at increased risk for low 25-hydroxyvitamin D. The odds ratio for low 25-hydroxyvitamin D was 4.07 for girls versus boys, with a 95% confidence interval of 1.18-13.97; for each 1-unit increase in body mass index, the odds ratio was 1.179, with a 95% confidence interval of 1.047-1.329. Use of newer antiepileptic drugs was not associated with altered risk, compared with older enzyme-inducing drugs. Vitamin D insufficiency was highly prevalent in this unselected population of children with epilepsy. Female sex and increased body mass index were significant risk factors for low vitamin D levels, but antiepileptic drug regimen was not.
Shellhaas
Renée A
RA
Division of Pediatric Neurology, Department of Pediatrics and Communicable Diseases, Ann Arbor, MI, USA. shellhaa@med.umich.edu
Barks
Amanda K
AK
Joshi
Sucheta M
SM
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D004827:Epilepsy / Q000150:complications* / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D016017:Odds Ratio; D015995:Prevalence; D012044:Regression Analysis; D012307:Risk Factors; D014808:Vitamin D Deficiency / Q000150:complications / Q000453:epidemiology*
J Pediatr. 2009 Jan;154(1):132-4
19187735
Epilepsia. 2001 Sep;42(9):1141-7
11580761
Pediatrics. 2009 Mar;123(3):797-803
19255005
Bone. 2008 Jul;43(1):149-155
18467202
Pediatrics. 2009 Sep;124(3):e371-9
19661053
Pediatr Neurol. 2006 Sep;35(3):177-81
16939856
Epilepsia. 1979 Feb;20(1):3-15
217680
Neurology. 2006 Dec 12;67(11):2005-14
17159108
Epilepsy Behav. 2006 Dec;9(4):601-5
16971186
Am J Clin Nutr. 2008 Aug;88(2):558S-564S
18689402
Pediatrics. 2009 Sep;124(3):e362-70
19661054
Pediatrics. 2008 Nov;122(5):1142-52
18977996
Epilepsia. 2007 Jan;48(1):66-71
17241209
J Pediatr. 2009 Aug;155(2):260-5
19446841
J Pediatr Endocrinol Metab. 2005 Jun;18(6):585-8
16042326
Arch Pediatr Adolesc Med. 2008 Jun;162(6):513-9
18524740
J Am Diet Assoc. 2007 Jun;107(6):1014-8
17524723
J Pediatr Endocrinol Metab. 2000 Jul-Aug;13(7):933-9
10968482
Ann Epidemiol. 2009 Feb;19(2):73-8
18329892
Acta Neurol Scand. 2005 Nov;112(5):277-86
16218908
Neurology. 2009 Sep 1;73(9):658-64
19474413
J Child Neurol. 2006 May;21(5):411-4
16901447
Neurology. 2006 May 9;66(9):1318-24
16682661
Pediatr Neurol. 2008 Oct;39(4):266-71
18805365
J Child Neurol. 2006 Mar;21(3):205-9
16901421
J Pediatr. 1995 Aug;127(2):256-62
7636651
J Clin Endocrinol Metab. 1988 Aug;67(2):373-8
2839537
Epilepsia. 2006 Mar;47(3):510-5
16529614
Neurology. 2008 Jan 15;70(3):170-6
18057319